Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Receivables (2016 - 2025)

Phibro Animal Health has reported Change in Receivables over the past 13 years, most recently at -$2.3 million for Q4 2025.

  • Quarterly results put Change in Receivables at -$2.3 million for Q4 2025, down 106.67% from a year ago — trailing twelve months through Dec 2025 was $15.7 million (down 67.75% YoY), and the annual figure for FY2025 was $55.2 million, up 536.18%.
  • Change in Receivables for Q4 2025 was -$2.3 million at Phibro Animal Health, up from -$11.4 million in the prior quarter.
  • Over the last five years, Change in Receivables for PAHC hit a ceiling of $35.0 million in Q4 2024 and a floor of -$22.3 million in Q3 2022.
  • Median Change in Receivables over the past 5 years was $5.5 million (2022), compared with a mean of $4.5 million.
  • Biggest five-year swings in Change in Receivables: crashed 411.02% in 2022 and later skyrocketed 7819.86% in 2024.
  • Phibro Animal Health's Change in Receivables stood at $2.9 million in 2021, then skyrocketed by 154.85% to $7.5 million in 2022, then crashed by 120.44% to -$1.5 million in 2023, then soared by 2379.41% to $35.0 million in 2024, then plummeted by 106.67% to -$2.3 million in 2025.
  • The last three reported values for Change in Receivables were -$2.3 million (Q4 2025), -$11.4 million (Q3 2025), and $26.0 million (Q2 2025) per Business Quant data.